Abstract
Current imaging procedures for prostate cancer including positron emission tomography (PET) exhibit considerable limitations and are not always able to meet the diagnostic needs. Recently, a 68Gallium-labeled ligand of the prostate-specific membrane antigen (68Ga-PSMA) has been introduced in PET-imaging of prostate cancer with first promising results. Due to relatively exclusive expression of PSMA in prostatic tissue as well as increased expression in prostate cancer, 68 Ga-PSMA was reported to exhibit a favorable lesion to background ratio. Together with the novel development of combined PET/MRI, the combination of excellent morphological detail, multiparametric functional information, and molecular PET data might lead to a significant improvement in detection of prostate cancer. We present an exemplarily case of primary staging using multiparametric 68Ga-PSMA PET/MR by combining molecular and structural information.
Original language | English |
---|---|
Pages (from-to) | 1769-1771 |
Number of pages | 3 |
Journal | Abdominal Imaging |
Volume | 40 |
Issue number | 6 |
DOIs | |
State | Published - 12 Aug 2015 |
Keywords
- Ga-PSMA
- Multiparametric analysis
- PET/MR
- Prostate cancer
- Tumor biology